RxDoctor Payments Data

Danielle Goldberg

Optometrist · Norwalk, CTNPI 1710430061

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Alcon at 56.5% of the total. Reporting peaked in 2020 at $4,140 and has fallen 71.0% since, to $1,202 in 2025. Among optometrist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,127in general payments, 2019–2025

Across 186 payments — averaging $59.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$6K
  • Coopervision Inc.$995
  • Bausch & Lomb Americas Inc.$862
  • Glaukos Corporation$639
  • Sun Pharmaceutical Industries Inc.$497
  • Oyster Point Pharma, Inc.$389
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$2,66024%
  • Travel & lodging$1,91817%
  • Food & beverage$6,52959%
  • Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,127 in reported general payments places this provider in the 95th percentile of 574 optometrist providers in Connecticut.

See all optometrist providers in Connecticut

Medicare billing

Part B allowed, 2024
$20,527
Medicare patients
139
Services billed
1,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost63$1,069
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat18$297
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha16$153

Paid to pharmacies, not to this prescriber.

Other optometrist in Norwalk

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →